Health chiefs are poised to approve the first-ever pill made specifically for women dealing with post-partum depression.
Massachusetts-based drugmakers Sage Therapeutics and Biogen said Monday the Food and Drug Administration (FDA) could approve the medication by August 6.
The medication zuranolone is an antidepressant drug that patients only need to take for two weeks. This is a stark contrast to the other medication on the market for postpartum depression (PPD), a drug called Zulresso, which needs to be administered via IV continuously for 60 hours.
Read more at: https://www.dailymail.co.uk/health/article-11719997/First-pill-postpartum-depression-rolled-AUGUST.html